Matthew L Smith

The Dietary Flavonoid Fisetin Causes Cell Cycle Arrest, Caspase‐Dependent Apoptosis, and Enhanced Cytotoxicity of Chemotherapeutic Drugs in Triple‐Negative Breast Cancer Cells

Matthew L Smith, Kaylee Murphy, Carolyn D. Doucette et al. · Journal of Cellular Biochemistry · 2016 · 86 citations

Breast Oncology, Chemoprevention Strategy, Caspase‐dependent Apoptosis +16

Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT): a single-arm, multicentre, phase 1/2 trial

Mhairi Copland, Daniel Slade, Graham McIlroy et al. · The Lancet Haematology · 2021 · 51 citations

Phase 1/2, Hematological Malignancy, Oncology +7

Clinical impact of <i>NPM1</i>-mutant molecular persistence after chemotherapy for acute myeloid leukemia

Ing Soo Tiong, Richard Dillon, Adam Ivey et al. · Blood Advances · 2021 · 37 citations · Full text

Hematological Malignancy, Npm1 Mutant, Health Sciences +15

The role of 3D printing in preoperative planning for heart transplantation in complex congenital heart disease

Matthew L Smith, Jonathan McGuinness, Michael K. O’Reilly et al. · Irish Journal of Medical Science (1971 -) · 2017 · 33 citations

Engineering, Pediatric Heart Disease, Bioprinting +9

Combination Adriamycin and radiation therapy in gynecologic cancers

Watson G. Watring, J.E. Byfield, Leo D. Lagasse et al. · Gynecologic Oncology · 1974 · 29 citations

Radiation Medicine, Radiation Therapy, Medicine +6